Latest Cyclopyrrolones Stories
Sepracor Inc. (Nasdaq: SEPR) today announced the presentation of Phase III combined clinical results for eslicarbazepine acetate (SEP-0002093 / BIA 2-093) in the treatment of epilepsy at the Ninth Eilat Conference on New Anti-Epileptic Drugs in Spain.
Cognitive behavioral therapy (CBT), a counseling method that emphasizes the role of thinking and behavior modification, is more effective than zopiclone for the short- and long-term treatment of chronic insomnia in older adults, according to a new report. In fact, the study found that zopiclone was no more effect for insomnia than placebo was (a sugar pill.)
By Toni Clarke BOSTON (Reuters) - When Dr. Gerald Maguire was a child, he resolved every New Year's Eve to stop stuttering. The resolution usually lasted less than two hours.
When Dr. Gerald Maguire was a child, he resolved every New Year's Eve to stop stuttering. The resolution usually lasted less than two hours.
Strange behavior by insomniacs taking prescription drugs, ranging from binge eating to having sex while asleep, have raised safety questions about anti-insomnia medications like Sanofi-Aventis' Ambien.
Insomniacs can now try another sleeping pill for desperately needed slumber. Lunesta, from Sepracor Inc., is the latest entry into the sleep medication market, and it has the distinction of being the only such medication approved for long-term use by the U.S. Food and Drug Administration (FDA).
- Growing in low tufty patches.